Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01482169 · ClinicalTrials.gov registry record · NA
Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)
A NA study, sponsored by Ochsner Health System.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT01482169: Completed NA study, sponsored by Ochsner Health System.
NCT01482169 is a NA study that has completed, run by Ochsner Health System. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01482169, a NA study, has completed, sponsored by Ochsner Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that intravenous regadenoson is equivalent to intravenous Adenoscan® for the physiological assessment of intermediate coronary lesions.
Primary Outcome
For the first measurement of FFR, the subject will receive Adenoscan® by IV infusion. Then the FFR measurements will be taken. When vital signs have returned to normal, after two minutes the line will be flushed with saline. The subject will then receive Regadenoson by IV infusion and repeat FFR measurements will be recorded. The subject will be administered aminophylline and the time duration it takes to return to baseline hemodynamic will be recorded.
Interventions
- DRUG FFR Measurement with IV Adenoscan® then with Regadenoson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT01482169 record still lists
NCT01482169 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which FFR Measurement with IV Adenoscan® then with Regadenoson is the first listed.
NCT01482169 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01482169 about?
NCT01482169 is a clinical study titled "Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)". The purpose of this study is to demonstrate that intravenous regadenoson is equivalent to intravenous Adenoscan® for the physiological assessment of intermediate coronary lesions.
What is the current status of trial NCT01482169?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2012-03. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01482169?
The interventions under investigation include: FFR Measurement with IV Adenoscan® then with Regadenoson (DRUG).
Who is sponsoring clinical trial NCT01482169?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01482169's enrollment target sits among peer trials
48 1381st of 2000 higher than 601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia